Annual report pursuant to Section 13 and 15(d)

BASIS OF PRESENTATION (Detail Textual)

v3.19.2
BASIS OF PRESENTATION (Detail Textual) - $ / shares
1 Months Ended
Oct. 29, 2018
Feb. 13, 2015
Mar. 31, 2019
Mar. 31, 2018
Disclosure Text Block [Abstract]        
Common Stock, Par or Stated Value Per Share     $ 0.001 $ 0.001
Stockholders' Equity, Reverse Stock Split the Company effected a reverse stock split and thereafter Bionik’s common stock began trading on the OTCQB market on a one-for-one hundred and fifty (1:150) split-adjusted basis. the Company implemented a 1-for-0.831105 reverse stock split of the common stock, which had previously been approved on September 24, 2014.